Recurrent Verrucous Carcinoma of the Larynx Active Not Recruiting Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0029506 (Recurrent Verrucous Carcinoma of the Larynx)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01847326Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerTreatment